Clinical Care Options HIV - CCO Expert Recap of data from the 2006 Conference on Retroviruses and Opportunistic Infections

CCO Expert Recap

CCO Expert Recap of data from the 2006 Conference on Retroviruses and Opportunistic Infections

Source: 2006 Conference on Retroviruses and Opportunistic Infections*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update From 2006 CROI: First-line Therapy, Pharmacology, Metabolics

Faculty:

Joel E. Gallant, MD, MPH
Richard E. Chaisson, MD
Joseph J. Eron, Jr., MD

Courtney V. Fletcher, PharmD
W. David Hardy, MD
Sally Hodder, MD

Bruce Polsky, MD
Mauro Schechter, MD, PhD
Kimberly Y. Smith, MD, MPH

Kathleen E. Squires, MD
Andrew R. Zolopa, MD

CME CREDIT INFORMATION

Release Date: 03/31/06

Expiration Date: 03/30/07

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Status: Please log in to view status

CCO Expert Recap combining slides with audio commentary by Joel E. Gallant, MD, MPH. Topics covered include: First-line Regimens Pharmacology and Adverse Events Metabolic Complications and Lipodystrophy

Learning Objectives

Upon completion of this activity, participants should be able to:

List the recently reported results of clinical and basic studies of all classes of antiretroviral therapy agents used in the treatment of HIV
Discuss the epidemiology and pathogenesis of lipodystrophy
Describe strategies for management of lipodystrophy and complications occuring in patients receiving antiretroviral therapy
Review new evidence concerning pharmacologic interactions and side effects that may occur in patients receiving antiretroviral therapy